Gevertz2018 - Cancer Treatment with Oncolytic Viruses and Dendritic Cell injections original model Lab
About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
The model is based on 'Developing a Minimally Structured Mathematical Model of Cancer Treatment with Oncolytic Viruses and Dendritic Cell Injections', PMID:30510594. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "c_kill_source_parameter",
"label": "C kill source parameter",
"units": "native SBML value",
"default": 0.595397,
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.c_kill_source_parameter",
"description": "C kill source parameter. Maps to bundled SBML parameter `c_kill`."
},
{
"name": "ov_dose_source_parameter",
"label": "OV dose source parameter",
"units": "native SBML value",
"default": 2.5,
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.ov_dose_source_parameter",
"description": "OV dose source parameter. Maps to bundled SBML parameter `OV_dose`."
},
{
"name": "initial_uninfected_tumor_cell_u",
"label": "Uninfected Tumor Cell U",
"units": "native SBML value",
"default": 58.020755,
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.initial_uninfected_tumor_cell_u",
"description": "Initial Uninfected Tumor Cell U. Sets the initial value of bundled SBML symbol `Uninfected_Tumor_Cell_U`."
},
{
"name": "initial_tumor_targeting_t_cells_t",
"label": "Tumor targeting T cells T",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.initial_tumor_targeting_t_cells_t",
"description": "Initial Tumor targeting T cells T. Sets the initial value of bundled SBML symbol `Tumor_targeting_T_cells_T`."
},
{
"name": "initial_infected_cancer_cell_i",
"label": "Infected Cancer Cell I",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.initial_infected_cancer_cell_i",
"description": "Initial Infected Cancer Cell I. Sets the initial value of bundled SBML symbol `Infected_Cancer_Cell_I`."
},
{
"name": "initial_naive_t_cells_a",
"label": "Naive T cells A",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.initial_naive_t_cells_a",
"description": "Initial Naive T cells A. Sets the initial value of bundled SBML symbol `Naive_T_cells_A`."
}
],
"outputs": [
{
"name": "uninfected_tumor_cell_u",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.uninfected_tumor_cell_u",
"description": "Uninfected Tumor Cell U observable. Maps to SBML symbol `Uninfected_Tumor_Cell_U`."
},
{
"name": "tumor_targeting_t_cells_t",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.tumor_targeting_t_cells_t",
"description": "Tumor targeting T cells T observable. Maps to SBML symbol `Tumor_targeting_T_cells_T`."
},
{
"name": "infected_cancer_cell_i",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.infected_cancer_cell_i",
"description": "Infected Cancer Cell I observable. Maps to SBML symbol `Infected_Cancer_Cell_I`."
},
{
"name": "naive_t_cells_a",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.naive_t_cells_a",
"description": "Naive T cells A observable. Maps to SBML symbol `Naive_T_cells_A`."
},
{
"name": "dendritic_cells_d",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.dendritic_cells_d",
"description": "Dendritic Cells D observable. Maps to SBML symbol `Dendritic_Cells_D`."
},
{
"name": "oncolytic_adenovirus_v",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.oncolytic_adenovirus_v",
"description": "Oncolytic Adenovirus V observable. Maps to SBML symbol `Oncolytic_Adenovirus_V`."
},
{
"name": "state",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"immunotherapy",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth",
"virotherapy"
],
"title": "Gevertz2018 - Cancer Treatment with Oncolytic Viruses and Dendritic Cell injections original model Lab",
"models": [
{
"path": "models/core",
"alias": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model_state"
],
"from": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.state"
},
{
"to": [
"visualisation.oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model_summary"
],
"from": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model_species_labels"
],
"from": "oncology_sbml_gevertz2018_cancer_treatment_with_oncolytic_viru_biomd0000000816_model.species_labels"
}
],
"package": "gevertz2018-cancer-treatment-with-oncolytic-viruses-and-0a3c719a",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "The model is based on 'Developing a Minimally Structured Mathematical Model of Cancer Treatment with Oncolytic Viruses and Dendritic Cell Injections', PMID:30510594. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagegevertz2018-cancer-treatment-with-oncolytic-viruses-and-0a3c719a
Created2026-05-16
Updated2026-06-13
biomodels_ebicurateddrug-responsefaithfulimmunotherapyoncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvirotherapyvisualisationother